Products for Research Use Only
RegisterLogin

Riociguat-13C, d6

CAT: 0804-HY-14779SSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-14779SSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Riociguat-13C, d6 is the 13C and deuterium labeled Riociguat. Riociguat is an oral stimulator of soluble guanylate cyclase (sGC) used in the treatment of pulmonary hypertension.
Product Name Alternative
BAY 632521-13C, d6
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Purity
99.0
Solubility
10 mM in DMSO|DMF : ≥ 10mg/mL|DMSO : ≥ 10mg/mL
Smiles
O=C(OC([2H])([2H])[2H])N(C1=C(N)N=C(C2=NN(CC3=CC=CC=C3F)C4=NC=CC=C42)N=C1N)[13C]([2H])([2H])[2H]
Molecular Formula
C19 13CH13D6FN8O2
Molecular Weight
429.45
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-223.|[2]Schermuly RT, et al. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J. 2008 Oct;32 (4) :881-91. |[3]Schermuly RT, et al. Riociguat for the treatment of pulmonary hypertension.Expert Opin Investig Drugs. 2011 Apr;20 (4) :567-76.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
Phase 4

Related Products

CatalogName
HY-14779S2Riociguat-13C, d3
HY-17492S2-01Zafirlukast-13C, d6
HY-13693S2-01Mometasone furoate-13C, d6
HY-14779-01Riociguat
HY-14779R-01Riociguat (Standard)
HY-W294556S-011-Benzyl-4-methylenepiperidine-13C, d6
HY-14779S3Riociguat-d3
HY-143683S-01Theophylline-13C2, d6
HY-W750238Scoparone-13C2, d6
HY-B1912S1-01Amidosulfuron-13C2, d6

Alternative Products

CatalogName
TRC-R520004-1MGRiociguat-13C-d3
TMIH-0497-01Riociguat-13C-d6
CS-O-15618Riociguat-13C, d3
A3767-50Riociguat

Popular Products